Research ArticleCARDIOVASCULAR
A Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice
Kenji Kuwabara, Kohji Murakami, Makoto Todo, Tomiyoshi Aoki, Tetsuo Asaki, Masatoshi Murai and Junichi Yano
Journal of Pharmacology and Experimental Therapeutics June 2004, 309 (3) 970-977; DOI: https://doi.org/10.1124/jpet.103.064659
Kenji Kuwabara
Kohji Murakami
Makoto Todo
Tomiyoshi Aoki
Tetsuo Asaki
Masatoshi Murai
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 3
1 Jun 2004
Research ArticleCARDIOVASCULAR
A Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice
Kenji Kuwabara, Kohji Murakami, Makoto Todo, Tomiyoshi Aoki, Tetsuo Asaki, Masatoshi Murai and Junichi Yano
Journal of Pharmacology and Experimental Therapeutics June 1, 2004, 309 (3) 970-977; DOI: https://doi.org/10.1124/jpet.103.064659
Research ArticleCARDIOVASCULAR
A Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice
Kenji Kuwabara, Kohji Murakami, Makoto Todo, Tomiyoshi Aoki, Tetsuo Asaki, Masatoshi Murai and Junichi Yano
Journal of Pharmacology and Experimental Therapeutics June 1, 2004, 309 (3) 970-977; DOI: https://doi.org/10.1124/jpet.103.064659
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement